Clinical Evaluation of Medetomidine a Novel Sedative and Analgesic Drug for Dogs and Cats

摘要

Medetomidine, a potent α2-adrenoceptor agonist, was investigated in open, multicenter clinical trials with patients of various canine and feline breeds (1736 dogs and 678 cats). The purpose of the study was to find an optimal dose of medetomidine for sedation and analgesia in clinical practice and to study how well the intended procedure could be performed under the influence of the drug.